Resultados de la búsqueda 541-550 of 10746 for 搜索留痕关键词咨询邮箱：lgooxc@hotmail.com

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Scottsdale/Phoenix, Ariz. The purpose of this study is to determine: the incidence of hemorrhage in the 3 months following deep vein thrombosis diagnosis in ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Scottsdale/Phoenix, Ariz. The purpose of this study is to determine: the incidence of hemorrhage in the 3 months following deep vein thrombosis diagnosis in ...

  3. Hematología - Ensayos clínicos

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Scottsdale/Phoenix, Ariz. The purpose of this study is to determine: the incidence of hemorrhage in the 3 months following deep vein thrombosis diagnosis in ...

  5. Perdidos en el espacio - Mayo Clinic

    VID-20078298. Estilo de vida saludable · Salud del adulto · Multimedia; Lost in Space. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  6. Médicos - Medicina de laboratorio y patología - Mayo Clinic

    Md Shahrier Amin, M.B.B.S., Ph.D. Jacksonville, FL. Marie-Christine Aubry, M.D.. Rochester, MN.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study will also test what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the perfomance a MR-based imaging technology (named Slip Interface Imaging) in predicting extraprostatic extension in ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus MabThera/Rituxan ( ...